{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:24:03Z","timestamp":1793132643879,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T00:00:00Z","timestamp":1573862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T00:00:00Z","timestamp":1573862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s12325-019-01130-1","type":"journal-article","created":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T10:02:39Z","timestamp":1573898559000},"page":"603-616","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["Recognising Skin Cancer in Primary Care"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2783-9431","authenticated-orcid":false,"given":"Owain T.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charindu K. I.","family":"Ranmuthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per N.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garth","family":"Funston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona M.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,16]]},"reference":[{"key":"1130_CR1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","volume":"103","author":"J Ferlay","year":"2018","unstructured":"Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356\u201387.","journal-title":"Eur J Cancer"},{"key":"1130_CR2","unstructured":"Cancer Research UK About melanoma. https:\/\/www.cancerresearchuk.org\/about-cancer\/melanoma\/about. Accessed 30 Aug 2019."},{"key":"1130_CR3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejca.2016.05.005","volume":"63","author":"C Garbe","year":"2016","unstructured":"Garbe C, Peris K, Hauschild A, et al. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline\u2014update 2016. Eur J Cancer. 2016;63:201\u201317.","journal-title":"Eur J Cancer"},{"issue":"11","key":"1130_CR4","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/bjc.2011.430","volume":"105","author":"M Mistry","year":"2011","unstructured":"Mistry M, Parkin DM, Ahmad AS, Sasieni P. Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer. 2011;105(11):1795\u2013803.","journal-title":"Br J Cancer"},{"issue":"1","key":"1130_CR5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jaad.2014.09.036","volume":"72","author":"C Karimkhani","year":"2015","unstructured":"Karimkhani C, Boyers LN, Dellavalle RP, Weinstock MA. It\u2019s time for \u201ckeratinocyte carcinoma\u201d to replace the term \u201cnonmelanoma skin cancer\u201d. J Am Acad Dermatol. 2015;72(1):186\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"1130_CR6","unstructured":"Cancer Research UK. Non-melanoma skin cancer statistics. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/non-melanoma-skin-cancer#heading-Zero. Accessed 30 Aug 2019."},{"key":"1130_CR7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-662-47081-7_1","volume-title":"High-risk cutaneous squamous cell carcinoma: a practical guide for patient management","author":"PS Karia","year":"2016","unstructured":"Karia PS. Epidemiology and outcomes of cutaneous squamous cell carcinoma. In: Schmults CD, editor. High-risk cutaneous squamous cell carcinoma: a practical guide for patient management. Berlin: Springer; 2016. p. 3\u201328."},{"issue":"s1","key":"1130_CR8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/bjc.2015.23","volume":"112","author":"SC Hiom","year":"2015","unstructured":"Hiom SC. Diagnosing cancer earlier: reviewing the evidence for improving cancer survival. Br J Cancer. 2015;112(s1):S1\u20135.","journal-title":"Br J Cancer"},{"issue":"1","key":"1130_CR9","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1186\/s12885-015-1865-x","volume":"15","author":"W Hamilton","year":"2015","unstructured":"Hamilton W, Stapley S, Campbell C, Lyratzopoulos G, Rubin G, Neal RD. For which cancers might patients benefit most from expedited symptomatic diagnosis? Construction of a ranking order by a modified Delphi technique. BMC Cancer. 2015;15(1):820.","journal-title":"BMC Cancer"},{"issue":"666","key":"1130_CR10","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.3399\/bjgp17X694169","volume":"68","author":"R Swann","year":"2018","unstructured":"Swann R, McPhail S, Witt J, et al. Diagnosing cancer in primary care: results from the national cancer diagnosis audit. Br J Gen Pract. 2018;68(666):e63\u201372.","journal-title":"Br J Gen Pract"},{"key":"1130_CR11","unstructured":"Public Health England. National Cancer Intelligence Network Be Clear on Cancer: skin cancer awareness local pilot campaign. Interim evaluation results. 2016. London: Public Health England."},{"key":"1130_CR12","unstructured":"Cancer Research UK. Melanoma skin cancer incidence statistics. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/melanoma-skin-cancer\/incidence. Accessed 30 Aug 2019."},{"issue":"8","key":"1130_CR13","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/s41416-018-0029-6","volume":"118","author":"KF Brown","year":"2018","unstructured":"Brown KF, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br J Cancer. 2018;118(8):1130\u201341.","journal-title":"Br J Cancer"},{"key":"1130_CR14","unstructured":"Cancer Research UK. Melanoma skin cancer risk. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/melanoma-skin-cancer\/risk-factors#heading-Two. Accessed 30 Aug 2019."},{"issue":"2","key":"1130_CR15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaad.2018.03.060","volume":"80","author":"MC Cameron","year":"2019","unstructured":"Cameron MC, Lee E, Hibler BP, et al. Basal cell carcinoma: epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J Am Acad Dermatol. 2019;80(2):303\u201317.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1130_CR16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejca.2004.10.015","volume":"41","author":"S Gandini","year":"2005","unstructured":"Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer. 2005;41(1):28\u201344.","journal-title":"Eur J Cancer"},{"issue":"s61","key":"1130_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2133.146.s61.2.x","volume":"146","author":"TL Diepgen","year":"2002","unstructured":"Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol. 2002;146(s61):1\u20136.","journal-title":"Br J Dermatol"},{"issue":"s2","key":"1130_CR18","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1524-4725.2004.30089.x","volume":"30","author":"M Zak-Prelich","year":"2004","unstructured":"Zak-Prelich M, Narbutt J, Sysa-Jedrzejowska A. Environmental risk factors predisposing to the development of basal cell carcinoma. Dermatol Surg. 2004;30(s2):248\u201352.","journal-title":"Dermatol Surg"},{"issue":"2","key":"1130_CR19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/ijd.12553","volume":"54","author":"JR Kallini","year":"2015","unstructured":"Kallini JR, Hamed N, Khachemoune A. Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends. Int J Dermatol. 2015;54(2):130\u201340.","journal-title":"Int J Dermatol"},{"issue":"21","key":"1130_CR20","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1056\/NEJMra044151","volume":"353","author":"AI Rubin","year":"2005","unstructured":"Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med. 2005;353(21):2262\u20139.","journal-title":"N Engl J Med"},{"issue":"4","key":"1130_CR21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.sder.2012.08.005","volume":"31","author":"V Nikolaou","year":"2012","unstructured":"Nikolaou V, Stratigos AJ, Tsao H. Hereditary nonmelanoma skin cancer. Semin Cutan Med Surg. 2012;31(4):204\u201310.","journal-title":"Semin Cutan Med Surg"},{"key":"1130_CR22","unstructured":"National Institute for Health and Care Excellence. Sunlight exposure: risks and benefits. NG34. London: NICE; 2016."},{"issue":"11","key":"1130_CR23","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1001\/jama.2018.1623","volume":"319","author":"Behavioral Counseling to Prevent Skin Cancer","year":"2018","unstructured":"Behavioral Counseling to Prevent Skin Cancer. US preventive services task force recommendation statement. JAMA. 2018;319(11):1134\u201342.","journal-title":"JAMA"},{"key":"1130_CR24","unstructured":"National Institute for Health and Care Excellence. Melanoma and pigmented lesions\u2014clinical knowledge summary. https:\/\/cks.nice.org.uk\/melanoma-and-pigmented-lesions#!scenario. Accessed 30 Aug 2019."},{"key":"1130_CR25","unstructured":"The Royal Australian College of General Practitioners \u2018Red Book\u2019 Taskforce. Guidelines for preventive activities in general practice (\u201cThe Red Book\u201d). 9th ed. South Melbourne: RACGP; 2018."},{"issue":"1","key":"1130_CR26","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.2044-8287.2012.02089.x","volume":"18","author":"AL Williams","year":"2013","unstructured":"Williams AL, Grogan S, Clark-Carter D, Buckley E. Appearance-based interventions to reduce ultraviolet exposure and\/or increase sun protection intentions and behaviours: a systematic review and meta-analyses. Br J Health Psychol. 2013;18(1):182\u2013217.","journal-title":"Br J Health Psychol"},{"key":"1130_CR27","unstructured":"Cancer Research UK. Sun, UV and cancer. https:\/\/www.cancerresearchuk.org\/about-cancer\/causes-of-cancer\/sun-uv-and-cancer. Accessed 30 Aug 2019."},{"key":"1130_CR28","doi-asserted-by":"crossref","first-page":"194","DOI":"10.7326\/0003-4819-150-3-200902030-00009","volume":"150","author":"T Wolff","year":"2009","unstructured":"Wolff T, Tai E, Miller T. Screening for skin cancer : an update of the evidence for the US. Preventive services task force. Ann Intern Med. 2009;150:194\u20138.","journal-title":"Ann Intern Med"},{"key":"1130_CR29","doi-asserted-by":"crossref","unstructured":"Johansson M, Brodersen J, Gotzsche PC, Jorgensen KJ. Screening for reducing morbidity and mortality in malignant melanoma. Cochrane Database Syst Rev. 2019;(6):CD012352.","DOI":"10.1002\/14651858.CD012352.pub2"},{"key":"1130_CR30","unstructured":"Williams LH, Shors AR, Barlow WE, Solomon C, White E. Identifying persons at highest risk of melanoma using self-assessed risk factors. J Clin Exp Dermatol Res. 2011;2(6):1000129."},{"issue":"8","key":"1130_CR31","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1158\/1055-9965.EPI-14-0295","volume":"23","author":"JA Usher-Smith","year":"2014","unstructured":"Usher-Smith JA, Emery J, Kassianos AP, Walter FM. Risk prediction models for melanoma: a systematic review. Cancer Epidemiol Biomarkers Prev. 2014;23(8):1450\u201363.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"1130_CR32","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/bjd.15181","volume":"176","author":"JA Usher-Smith","year":"2017","unstructured":"Usher-Smith JA, Kassianos AP, Emery JD, et al. Identifying people at higher risk of melanoma across the UK: a primary-care-based electronic survey. Br J Dermatol. 2017;176(4):939\u201348.","journal-title":"Br J Dermatol"},{"issue":"4","key":"1130_CR33","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3322\/canjclin.48.4.232","volume":"48","author":"L Hill","year":"2008","unstructured":"Hill L, Ferrini RL. Skin cancer prevention and screening: summary of the American College of Preventive Medicine\u2019s practice policy statements. CA Cancer J Clin. 2008;48(4):232\u20135.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1130_CR34","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/bjd.14477","volume":"174","author":"I Hoorens","year":"2016","unstructured":"Hoorens I, Vossaert K, Ongenae K, Brochez L. Is early detection of basal cell carcinoma worthwhile? Systematic review based on the WHO criteria for screening. Br J Dermatol. 2016;174(6):1258\u201365.","journal-title":"Br J Dermatol"},{"issue":"7","key":"1130_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2014-005566","volume":"4","author":"FM Walter","year":"2014","unstructured":"Walter FM, Birt L, Cavers D, et al. \u201cThis isn\u2019t what mine looked like\u201d: a qualitative study of symptom appraisal and help seeking in people recently diagnosed with melanoma. BMJ Open. 2014;4(7):1\u201312.","journal-title":"BMJ Open"},{"issue":"3","key":"1130_CR36","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0025-6196(11)61033-1","volume":"82","author":"S Markovic","year":"2007","unstructured":"Markovic S, Erickson L, Rao R, et al. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc. 2007;82(3):364\u201380.","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"1130_CR37","first-page":"476","volume":"38","author":"A Chamberlain","year":"2009","unstructured":"Chamberlain A, Ng J. Cutaneous melanoma\u2013atypical variants and presentations. Aust Fam Physician. 2009;38(7):476\u201382.","journal-title":"Aust Fam Physician"},{"issue":"12","key":"1130_CR38","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1001\/jamadermatol.2014.1348","volume":"150","author":"NE Thomas","year":"2014","unstructured":"Thomas NE, Kricker A, Waxweiler WT, et al. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study. JAMA Dermatol. 2014;150(12):1306\u201314.","journal-title":"JAMA Dermatol"},{"key":"1130_CR39","doi-asserted-by":"crossref","first-page":"k826","DOI":"10.1136\/bmj.k826","volume":"360","author":"AJ Muinonen-Martin","year":"2018","unstructured":"Muinonen-Martin AJ, O\u2019Shea SJ, Newton-Bishop J. Amelanotic melanoma. BMJ. 2018;360:k826.","journal-title":"BMJ"},{"key":"1130_CR40","doi-asserted-by":"crossref","unstructured":"Newton-Bishop J, Bataille V, Gavin, et al. The prevention, diagnosis, referral and management of melanoma of the skin: concise guidelines. Royal College of Physicians & British Association of Dermatologists. Concise guidance to good practice series, no. 7. London: RCP; 2007.","DOI":"10.7861\/clinmedicine.7-3-283"},{"key":"1130_CR41","unstructured":"National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. NG12. London: NICE; 2015."},{"issue":"610","key":"1130_CR42","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.3399\/bjgp13X667213","volume":"63","author":"FM Walter","year":"2013","unstructured":"Walter FM, Prevost AT, Vasconcelos J, et al. Using the 7-point checklist as a diagnostic aid for pigmented skin lesions in general practice: a diagnostic validation study. Br J Gen Pract. 2013;63(610):e345\u201353.","journal-title":"Br J Gen Pract"},{"key":"1130_CR43","doi-asserted-by":"crossref","DOI":"10.15586\/codon.cutaneousmelanoma.2017","volume-title":"Clinical presentation and staging of melanoma. Cutaneous melanoma: etiology and therapy","author":"WH Ward","year":"2017","unstructured":"Ward WH, Lambreton F, Goel N, Yu JQ, Farma JM. Clinical presentation and staging of melanoma. Cutaneous melanoma: etiology and therapy. Brisbane: Codon; 2017."},{"issue":"3","key":"1130_CR44","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3322\/canjclin.35.3.130","volume":"35","author":"RJ Friedman","year":"1985","unstructured":"Friedman RJ, Rigel DS, Kopf AW. Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin. 1985;35(3):130\u201351.","journal-title":"CA Cancer J Clin"},{"key":"1130_CR45","unstructured":"National Institute for Health and Care Excellence. Cancer services guideline: improving outcomes for people with skin tumours including melanoma. CSG8. London: NICE; 2006."},{"issue":"673","key":"1130_CR46","doi-asserted-by":"crossref","first-page":"e566","DOI":"10.3399\/bjgp18X697901","volume":"68","author":"P Murchie","year":"2018","unstructured":"Murchie P, Adam R, Khor WL, et al. Impact of rurality on processes and outcomes in melanoma care: results from a whole-Scotland melanoma cohort in primary and secondary care. Br J Gen Pract. 2018;68(673):e566\u201375.","journal-title":"Br J Gen Pract"},{"issue":"3","key":"1130_CR47","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaad.2012.05.043","volume":"68","author":"S Krengel","year":"2013","unstructured":"Krengel S, Scope A, Dusza SW, Vonthein R, Marghoob AA. New recommendations for the categorization of cutaneous features of congenital melanocytic nevi. J Am Acad Dermatol. 2013;68(3):441\u201351.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"1130_CR48","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0190-9622(92)70144-5","volume":"26","author":"DE Rowe","year":"1992","unstructured":"Rowe DE, Carroll RJ, Day CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol. 1992;26(6):976\u201390.","journal-title":"J Am Acad Dermatol"},{"key":"1130_CR49","unstructured":"Motley RJ, Preston PW, Lawrence CM. Multi-professional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. London: British Association of Dermatologists; 2009."},{"key":"1130_CR50","unstructured":"Primary Care Dermatology Society. Squamous cell carcinoma. http:\/\/www.pcds.org.uk\/clinical-guidance\/squamous-cell-carcinoma. Accessed 30 Aug 2019."},{"key":"1130_CR51","volume-title":"Suspected cancer in primary care","author":"New Zealand Guidelines Group","year":"2009","unstructured":"New Zealand Guidelines Group. Suspected cancer in primary care. Wellington: Ministry of Health; 2009."},{"issue":"6","key":"1130_CR52","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jaad.2015.11.033","volume":"74","author":"B Kwiek","year":"2016","unstructured":"Kwiek B, Schwartz RA. Keratoacanthoma (KA): an update and review. J Am Acad Dermatol. 2016;74(6):1220\u201333.","journal-title":"J Am Acad Dermatol"},{"key":"1130_CR53","unstructured":"National Institute for Health and Care Excellence. Improving outcomes for people with skin tumours including melanoma: evidence update October 2011. London: NICE; 2011."},{"issue":"4","key":"1130_CR54","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1365-4632.2011.05066.x","volume":"51","author":"SE Mcclain","year":"2012","unstructured":"Mcclain SE, Mayo KB, Shada AL, Smolkin ME, Patterson JW, Slingluff CL. Amelanotic melanomas presenting as red skin lesions: a diagnostic challenge with potentially lethal consequences. Int J Dermatol. 2012;51(4):420\u20136.","journal-title":"Int J Dermatol"},{"issue":"1","key":"1130_CR55","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0190-9622(92)70160-H","volume":"27","author":"ME Maloney","year":"1992","unstructured":"Maloney ME, Jones DB, Mack Sexton F. Pigmented basal cell carcinoma: investigation of 70 cases. J Am Acad Dermatol. 1992;27(1):74\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1130_CR56","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1524-4725.1981.tb00662.x","volume":"7","author":"SJ Salasche","year":"1981","unstructured":"Salasche SJ, Amonette RA. Morpheaform basal-cell epitheliomas. J Dermatol Surg Oncol. 1981;7(5):387\u201394.","journal-title":"J Dermatol Surg Oncol"},{"key":"1130_CR57","unstructured":"Royal College of General Practitioners. Guidance and competences to support the accreditation of GPs with Extended Roles (GPwERs) in dermatology and skin surgery. London: RCP; 2018."},{"issue":"7","key":"1130_CR58","first-page":"482","volume":"41","author":"C Rosendahl","year":"2012","unstructured":"Rosendahl C, Cameron A, McColl I, Wilkinson D. Dermatoscopy in routine practice\u2014\u201cchaos and clues\u201d. Aust Fam Physician. 2012;41(7):482\u20137.","journal-title":"Aust Fam Physician."},{"key":"1130_CR59","unstructured":"National Institute for Health and Care Excellence. Melanoma: assessment and management. NG14. London: NICE; 2015."},{"issue":"1","key":"1130_CR60","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaad.2011.07.019","volume":"67","author":"G Argenziano","year":"2012","unstructured":"Argenziano G, Cerroni L, Zalaudek I, et al. Accuracy in melanoma detection: a 10-year multicenter survey. J Am Acad Dermatol. 2012;67(1):54\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"1130_CR61","doi-asserted-by":"publisher","unstructured":"Dinnes J, Deeks JJ, Chuchu N, et al. Visual inspection and dermoscopy, alone or in combination, for diagnosing keratinocyte skin cancers in adults. Cochrane Database Syst Rev. 2018;(12):CD011901. https:\/\/doi.org\/10.1002\/14651858.cd011901.pub2.","DOI":"10.1002\/14651858.cd011901.pub2"},{"key":"1130_CR62","doi-asserted-by":"publisher","unstructured":"Dinnes J, Deeks JJ, Chuchu N, et al. Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults. Cochrane Database Syst Rev. 2018;(12):CD011902. https:\/\/doi.org\/10.1002\/14651858.cd011902.pub2.","DOI":"10.1002\/14651858.cd011902.pub2"},{"issue":"8","key":"1130_CR63","doi-asserted-by":"crossref","first-page":"e027529","DOI":"10.1136\/bmjopen-2018-027529","volume":"9","author":"O Jones","year":"2019","unstructured":"Jones O, Jurascheck L, van Melle M, et al. Dermoscopy for melanoma detection and triage in primary care: a systematic review. BMJ Open. 2019;9(8):e027529.","journal-title":"BMJ Open"},{"key":"1130_CR64","doi-asserted-by":"publisher","unstructured":"Chuchu N, Dinnes J, Takwoingi Y, et al. Teledermatology for diagnosing skin cancer in adults. Cochrane Database Syst Rev. 2018;(12):CD013193. https:\/\/doi.org\/10.1002\/14651858.cd013193.","DOI":"10.1002\/14651858.cd013193"},{"issue":"7866","key":"1130_CR65","doi-asserted-by":"crossref","first-page":"e4110","DOI":"10.1136\/bmj.e4110","volume":"345","author":"FM Walter","year":"2012","unstructured":"Walter FM, Morris HC, Humphrys E, et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ. 2012;345(7866):e4110.","journal-title":"BMJ"},{"issue":"2","key":"1130_CR66","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jval.2012.12.008","volume":"16","author":"ECF Wilson","year":"2013","unstructured":"Wilson ECF, Emery JD, Kinmonth AL, et al. The cost-effectiveness of a novel SIAscopic diagnostic aid for the management of pigmented skin lesions in primary care: a decision-analytic model. Value Health. 2013;16(2):356\u201366.","journal-title":"Value Health"},{"issue":"2","key":"1130_CR67","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/bjd.16924","volume":"180","author":"Y Fujisawa","year":"2019","unstructured":"Fujisawa Y, Otomo Y, Ogata Y, et al. Deep-learning-based, computer-aided classifier developed with a small dataset of clinical images surpasses board-certified dermatologists in skin tumour diagnosis. Br J Dermatol. 2019;180(2):373\u201381.","journal-title":"Br J Dermatol"},{"issue":"7","key":"1130_CR68","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S1470-2045(19)30333-X","volume":"20","author":"Philipp Tschandl","year":"2019","unstructured":"Tschandl P, Codella N, Akay BN, et al. Comparison of the accuracy of human readers versus machine-learning algorithms for pigmented skin lesion classification: an open, web-based, international, diagnostic study. Lancet Oncol. 2019;20(7):938\u201347.","journal-title":"The Lancet Oncology"},{"key":"1130_CR69","doi-asserted-by":"publisher","unstructured":"Dinnes J, Bamber J, Chuchu N, et al. High frequency ultrasound for the diagnosis of skin cancer in adults. Cochrane Database Syst Rev. 2018;(12):CD013188. https:\/\/doi.org\/10.1002\/14651858.cd013188.","DOI":"10.1002\/14651858.cd013188"},{"key":"1130_CR70","doi-asserted-by":"publisher","unstructured":"Ferrante di Ruffano L, Dinnes J, Deeks JJ, et al. Optical coherence tomography for the diagnosis of skin cancer in adults. Cochrane Database Syst Rev. 2018;(12):CD013189. https:\/\/doi.org\/10.1002\/14651858.cd013189.","DOI":"10.1002\/14651858.cd013189"},{"key":"1130_CR71","doi-asserted-by":"publisher","unstructured":"Dinnes J, Deeks JJ, Chuchu N, et al. Reflectance confocal microscopy for the diagnosis of cutaneous melanoma in adults. Cochrane Database Syst Rev. 2018;(12):CD013190. https:\/\/doi.org\/10.1002\/14651858.cd013190.","DOI":"10.1002\/14651858.cd013190"},{"key":"1130_CR72","doi-asserted-by":"publisher","unstructured":"Ferrante di Ruffano L, Takwoingi Y, Dinnes J, et al. Computer-assisted diagnosis techniques (dermoscopy and spectroscopy-based) for diagnosing skin cancer in adults. Cochrane Database Syst Rev. 2018;(12):CD013186. https:\/\/doi.org\/10.1002\/14651858.cd013186.","DOI":"10.1002\/14651858.cd013186"},{"issue":"10","key":"1130_CR73","first-page":"1158","volume":"33","author":"M Mogensen","year":"2007","unstructured":"Mogensen M, Jemec GBE. Diagnosis of nonmelanoma skin cancer\/keratinocyte carcinoma: a review of diagnostic accuracy of nonmelanoma skin cancer diagnostic tests and technologies. Dermatol Surg. 2007;33(10):1158\u201374.","journal-title":"Dermatol Surg"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-01130-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-019-01130-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-01130-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T00:36:07Z","timestamp":1605400567000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-019-01130-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,16]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1130"],"URL":"https:\/\/doi.org\/10.1007\/s12325-019-01130-1","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,16]]},"assertion":[{"value":"3 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}